Pay in 4 interest-free payments of $5.51 Learn more
-1.jpg&w=3840&q=75)
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Diabetes, 69 (7), 13821388
0.3 mL syringes work for separate cagrilintide doses
Medications like semaglutide and liraglutide have shown reductions in major adverse cardiovascular events (MACE) in patients with established cardiovascular disease
Semaglutide 2.4 mg (Wegovy): ~15% body weight loss at 68 weeks in clinical trials Tirzepatide 15 mg (Zepbound): ~21% body weight loss at 72 weeks in clinical trials Real-world data shows lower results: Cleveland Clinic research from 2025 found average weight loss of 7.7% with semaglutide and 12.4% with tirzepatide at one year in routine clinical practice
US$ 23.16
US$ 26.83
US$ 28.33
US$ 22.27
US$ 20.57
